Neurofibromatosis I and unexplained iron deficiency in two patients: Is iron depletion related to neurofibroma growth?

Journal of Neuro-Oncology

Volumn 75, Issue 2, 2005, Pages 227-228

  Moczygemba, Charmaine ^a,b   Bhattacharjee, Modushudan ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Iron deficiency; Iron supplementation; Neurofibroma; Neurofibromatosis I

Indexed keywords

IRON;

CAFE AU LAIT SPOT; CANCER GROWTH; DISEASE ASSOCIATION; HUMAN; IRON DEFICIENCY; IRON DEPLETION; IRON METABOLISM; IRON THERAPY; LETTER; NEUROFIBROMATOSIS;

ADULT; ANEMIA, IRON-DEFICIENCY; DIETARY SUPPLEMENTS; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HUMANS; IRON; IRON METABOLISM DISORDERS; MALE; MIDDLE AGED; NEUROFIBROMA; NEUROFIBROMATOSIS 1; REFERENCE STANDARDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 29244453922     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-3670-x     Document Type: Letter

References (3)

1. Arun D, Gutmann DH: Recent advances in neurofibromatosis type 1. Curr Opin Neurol 17(2): 101-105, 2004
2. Bohnsack BL, Hirschi KK: Nutrient regulation of cell cycle progression. Annu Rev Nutr 24: 433-453, 2004
3. Kuvibidila S, Gauthier T, Warrier RP, Rauford W: Increased levels of serum transferrin receptors and serum transferrin receptor/log ferritin ratios in men with prostate cancer and the implications for body-iron stores. J Lab Clin Med 144: 176-182